Research

Non-Invasive Hormonal Wellness Monitoring

A multi-modal approach combining facial biomarker analysis, cognitive performance testing, and structured symptom capture for longitudinal hormonal wellness tracking.

264
Participants
5
Data channels
70+
Symptom domains

Download the Full Research Paper

Methodology, dataset description, analysis approach, and findings from our 264-participant feasibility study across three hormonal status groups.

Download PDF

What's Inside

IntroductionThe measurement gap in hormonal health
BackgroundWhy blood tests fall short for perimenopause
MethodologyFive-channel data acquisition approach
Channel 1Facial biomarker analysis
Channel 2Cognitive performance battery
Channel 3Structured symptom capture
Dataset264 participants across 3 hormonal status groups
ResultsFeasibility findings and pattern analysis
DiscussionImplications for wellness monitoring
RegulatoryGeneral wellness product positioning

Key Highlights

Multi-Modal Approach

Five independent data channels (facial, cognitive, auditory, visual, symptom) fused into a single longitudinal wellness profile. No single channel provides sufficient signal alone.

Non-Invasive Collection

All data captured via standard smartphone. No blood draw, no lab visit, no specialized equipment. Enables repeatable monthly monitoring at scale.

264-Participant Dataset

Feasibility study across three hormonal status groups. Developed and tested on real clinical data from women aged 35-55.

Provider-Ready Output

Hundreds of signals distilled into structured intake reports designed for clinical conversations. Zero provider time investment for data collection.

See it in action

Try a free personal wellness check or learn how MARKABLE works for your organization.

Try Your Free Check For Clinics For Employers
MARKABLE is a general wellness product for personal awareness and self-monitoring. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The research described in this paper represents feasibility data. Prospective validation studies are in planning.